Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 1 , Pages 1-2 , March 2007

European platform for photodynamic medicine: Why?

  • K. Moghissi, MD, FRCS (Ed & Eng) (Editor in Chief)

      Affiliations

    • Corresponding Author InformationTel.: +44 1 724 290 456; fax: +44 1 724 290 456.

References 

  1. Hayata K, Kato H, Konaka C, Ono J, Takizawa N. Hamatoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest. 1983;51:50–56
  2. Hurubumi K, Jatsuo U, Tetsuya O, Kinya F. The history of the study of photodynamic therapy (PDT) and photodynamic diagnosis (PDD) in the Department of Surgery, Tokyo Medical University. Photodiag Photodyn Ther. 2004;1:107–110
  3. Von Tappeiner H, Jodlbauer A. On the effect of photodynamic (fluorescent) substances on protozoa and enzymes. Arch Klin Med. 1904;80:427–467
  4. Zheng H. Photodynamic therapy in China: over 25 years of unique clinical experience. Part one—history and domestic photosensitisers. Photodiag Photodyn Ther. 2006;3:3–10
  5. Zheng H. Photodynamic therapy in China over 25 years of unique clinical experience. Part two—clinical experience. Photodiag Photodyn Ther. 2006;3:71–84

PII: S1572-1000(07)00008-7

doi: 10.1016/j.pdpdt.2007.01.005

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 1 , Pages 1-2 , March 2007

Article Tools